MedTrace Logo

Effect of Ketone Esters in Parkinson's Disease

NCT04477161 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-01-04

No results posted yet for this study

Summary

Ketones esters have shown to improve mitochondrial function and are currently use to enhanced functional performance. As Mitochondrial dysfunction is one of the proposed mechanism of neuronal injury in Parkinson's disease, the study aims to assess the tolerability,side effects and effect of oral ketone esters in Patients with Parkinson's disease.

Conditions

  • Parkinson Disease
  • Ketosis

Interventions

DIETARY_SUPPLEMENT

Ketone Ester Elite endurance Nutrition Drink

Subjects will take one bottle four times daily for four weeks

OTHER

Stool Sample

Subjects will provide a stool sample at 2 timepoints.

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-05
Primary Completion
2020-11-05
Completion
2020-11-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04477161 on ClinicalTrials.gov